Prostate cancer is one of the most common malignancies and the second leading cause of cancer-related death in men in the United States. Progression of prostate cancer from its non-metastatic androgen-dependent phenotype to a more malignant metastatic androgen-independent phenotype is a slow and multi-step process that depends on both genetic and epigenetic factors. This slow progressing period provides a window for cancer prevention by intervention with compounds that interfere with specific stages of neoplastic progression. Poria cocos (P. Cocos) is a medicinal herb widely used in Asian countries for its sedative, diuretic, and tonic actions. Alcoholic extracts of P. cocos that are rich in lanostane-type triterpenoids have recently been shown to have anti-cancer and anti-inflammatory activities. However, the mechanism, efficacy, and safety of these triterpenoids in cancer treatment or prevention have not been systemically evaluated. Recently, in our preliminary experiments, we showed that extracts of P. cocos (PCE) (1) inhibit the growth of prostate cancer cells in vitro and in vivo (xenografts in nude mice) and (2) induce caspase-driven apoptosis in both androgen-dependent (LNCaP) and androgen-independent (DU145) human prostate carcinoma cells, indicating that triggering of apoptosis by PCE might occur independently of androgen responsiveness. The goals of this study are (1) to establish pachymic acid (PA), a triterpenoid and a major constituent of PCE, as a safe and effective anti-cancer agent for prostate cancer, and (2) to elucidate the potential molecular anticancer mechanism of PA. In particular, we will test the hypothesis that PA imparts cancer therapeutic and possibly cancer preventive effects by modulating the apoptotic machinery of prostate cancer cells via inhibition of phospholipase A2 (PLA2), removing potential downstream signals for AKT activation. To accomplish these objectives, we will employ LNCaP and DU145 prostate cancer cell lines to (1) determine the most effective and safe dose of PA for inhibition of cancer growth in nude mice with prostate cancer xenografts, and (2) define the molecular pathway through which PA induces prostate cancer cell apoptosis. Through this study, it is anticipated that the potential of PA as a novel and safe agent for treatment or prevention against prostate cancer will be identified. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
7R21CA115269-02
Application #
7116669
Study Section
Special Emphasis Panel (ZRG1-CDP (01))
Program Officer
Parnes, Howard L
Project Start
2005-07-15
Project End
2007-06-30
Budget Start
2006-05-12
Budget End
2006-06-30
Support Year
2
Fiscal Year
2005
Total Cost
$116,100
Indirect Cost
Name
National University of Singapore
Department
Type
DUNS #
595192253
City
Singapore
State
Country
Singapore
Zip Code
11907-7
Ling, Hui; Zhang, Yaochun; Ng, Ka-Yun et al. (2011) Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-?B-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat 126:609-20
Das, Surajit; Ng, Ka-Yun; Ho, Paul C (2011) Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations. J Drug Target 19:446-57
Das, Surajit; Chaudhury, Anumita; Ng, Ka-Yun (2011) Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release. Int J Pharm 406:11-20
Ling, Hui; Jia, Xiaobin; Zhang, Yaochun et al. (2010) Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells. Mol Carcinog 49:271-82
Das, Surajit; Ng, Ka-Yun (2010) Colon-specific delivery of resveratrol: optimization of multi-particulate calcium-pectinate carrier. Int J Pharm 385:20-8
Das, Surajit; Ng, Ka-Yun (2010) Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics. J Pharm Sci 99:840-60
Ling, Hui; Zhou, Liang; Jia, Xiaobin et al. (2009) Polyporenic acid C induces caspase-8-mediated apoptosis in human lung cancer A549 cells. Mol Carcinog 48:498-507
Zhang, Yao-Chun; Zhou, Liang; Ng, Ka-Yun (2009) Sesquiterpene lactones from Ixeris sonchifolia Hance and their cytotoxicities on A549 human non-small cell lung cancer cells. J Asian Nat Prod Res 11:294-8
Zhou, Liang; Zhang, Yaochun; Gapter, Leslie Adell et al. (2008) Cytotoxic and anti-oxidant activities of lanostane-type triterpenes isolated from Poria cocos. Chem Pharm Bull (Tokyo) 56:1459-62
Das, Surajit; Lin, Hai-Shu; Ho, Paul C et al. (2008) The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm Res 25:2593-600